The DARTS tool for assessing online medicines information.
OBJECTIVE
The use of the Internet as a source of medicines information is increasing. However, the quality of online information is highly variable. Equipping Internet users to distinguish good quality information is the aim of a new five-item quality assessment tool (DARTS) that was developed by the Working Group on Information to Patients under the Pharmaceutical Forum established by the European Commission. The objective of this study was to investigate how people with depression assess the quality of online medicines information and to study their opinions about the DARTS tool in assisting in this process.


METHODS
Focus group discussions with Internet users were conducted in metropolitan Helsinki, Finland.


METHODS
Six focus group discussions (67-109 min duration) were conducted with people with depression (n = 29). The DARTS tool was used as a stimulus after open discussion in relation to the evaluation of the quality of Internet-based medicines information. The focus groups were digitally audiotaped and transcribed verbatim. The transcripts were thematically content analysed by two researchers.


RESULTS
Focus group participants were generally critical of the information they retrieved. However, few participants systematically applied quality assessment criteria when retrieving online information. No participants had knowledge or experience of any quality assessment tools. The DARTS tool was perceived as being concise and easy to use and understand. Many participants indicated it would allay some of their concerns related to information quality and act as a reminder. While several participants felt the tool should not be any more extensive, some of them believed it should include a more in-depth explanation to accompany each of the quality criteria.


CONCLUSIONS
The DARTS tool may act as a prompt for people with depression to assess the quality of online information they obtain. The five DARTS criteria may form the basis of a systematic approach to quality assessment and the tool may also act as a reminder of quality issues in general. Further studies are needed to assess the actual value of the DARTS tool as well as its value in relation to other quality assessment instruments.
Närhi
Ulla
U
European Commission, Directorate-General for Enterprise and Industry, Unit F/2, Avenue l'Auderghem 45, Brussels, Belgium. ulla.narhi@ec.europa.eu
Pohjanoksa-Mäntylä
Marika
M
Karjalainen
Anna
A
Saari
Johanna K
JK
Wahlroos
Hannes
H
Airaksinen
Marja S
MS
Bell
Simon J
SJ
D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy*; D004346:Drug Information Services / Q000592:standards*; D005260:Female; D005387:Finland; D017144:Focus Groups; D006801:Humans; D020407:Internet / Q000592:standards*; D008297:Male; D008875:Middle Aged; D019984:Quality Indicators, Health Care; D011787:Quality of Health Care; D055815:Young Adult
D000928:Antidepressive Agents
J Med Internet Res. 2001 Oct-Dec;3(4):E28
11772543
Aust New Zealand Health Policy. 2005 Dec 07;2:29
16336646
JAMA. 1998 Feb 25;279(8):611-4
9486757
Br J Psychiatry. 2006 Sep;189:273-7
16946364
Cyberpsychol Behav. 2004 Oct;7(5):497-510
15667044
Res Social Adm Pharm. 2008 Jun;4(2):144-52
18555967
Pharm World Sci. 2007 Dec;29(6):688-94
17479353
JAMA. 2002 May 22-29;287(20):2691-700
12020305
JAMA. 2000 Mar 22-29;283(12):1600-6
10735398
Am J Med. 2002 Dec 15;113(9):740-5
12517364
Int J Ment Health Nurs. 2004 Dec;13(4):242-8
15660592
BMJ. 2002 Mar 9;324(7337):598-602
11884329
Stud Health Technol Inform. 2007;129(Pt 1):142-6
17911695
BMJ. 1995 Jul 29;311(7000):299-302
7633241
CNS Drugs. 2002;16(6):419-23
12027787
Int J Med Inform. 2005 Jan;74(1):13-9
15626632
Soc Psychiatry Psychiatr Epidemiol. 2005 Jan;40(1):1-10
15624068
Prev Chronic Dis. 2004 Oct;1(4):A13
15670445
Soc Sci Med. 2007 May;64(9):1853-62
17328998
J Affect Disord. 2009 Apr;114(1-3):333-9
18691765
Health Info Libr J. 2004 Sep;21 Suppl 2:14-26
15317572
BMJ. 2000 Jun 24;320(7251):1713-6
10864552
Med J Aust. 2002 Oct 7;177(S7):S122-5
12358571
Psychiatr Serv. 2003 Sep;54(9):1198
12954932
BMJ. 2000 Dec 16;321(7275):1511-5
11118181
Soc Sci Med. 2005 Oct;61(8):1821-7
16029778
Am J Med. 2002 Dec 15;113(9):763-5
12517369
BMC Public Health. 2007 Apr 10;7:53
17425798
Patient Educ Couns. 2003 Jun;50(2):151-5
12781930
JAMA. 1997 Apr 16;277(15):1244-5
9103351
J Med Internet Res. 2003 Dec 19;5(4):e33
14713661
Psychiatr Serv. 2001 Aug;52(8):1046-50
11474049
BMJ. 2000 Oct 7;321(7265):843-4
11021843
Prev Chronic Dis. 2006 Apr;3(2):A36
16539777